Roberta Gagliardi

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Editorial: Non-Selective Beta-Blockers in Decompensated Cirrhosis-More Friends Than Foes.

Editorial: Non-Selective Beta-Blockers in Decompensated Cirrhosis-More Friends Than Foes.

Journal: Alimentary pharmacology & therapeutics

Published: June 27, 2026

Relative Adrenal Insufficiency in Decompensated Cirrhosis With Hyponatremia: Disease Severity Marker or Therapeutic Target?

Relative Adrenal Insufficiency in Decompensated Cirrhosis With Hyponatremia: Disease Severity Marker or Therapeutic Target?

Journal: Journal of clinical and experimental hepatology

Published: June 24, 2026

Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.

Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 14, 2025

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.

Journal: Lancet (London, England)

Published: September 17, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.

Journal: JHEP reports : innovation in hepatology

Published: June 28, 2025

Impact of hepatocellular carcinoma on the risk of liver decompensation: A comparative analysis of patients with and without HCC.

Impact of hepatocellular carcinoma on the risk of liver decompensation: A comparative analysis of patients with and without HCC.

Journal: JHEP reports : innovation in hepatology

Published: June 03, 2025

Rectus femoris ultrasound identifies sarcopenia and predicts poor outcomes in patients with acute decompensation of cirrhosis.

Rectus femoris ultrasound identifies sarcopenia and predicts poor outcomes in patients with acute decompensation of cirrhosis.

Journal: JHEP reports : innovation in hepatology

Published: March 18, 2025

Risk of portal hypertensive complications preventable by TIPS in patients with ascites.

Risk of portal hypertensive complications preventable by TIPS in patients with ascites.

Journal: JHEP reports : innovation in hepatology

Published: January 20, 2025

Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease.

Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease.

Journal: Journal of hepatology

Published: August 15, 2024

Real-world experience with long-term albumin in patients with cirrhosis and ascites.

Real-world experience with long-term albumin in patients with cirrhosis and ascites.

Journal: JHEP reports : innovation in hepatology

Published: May 07, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026